FTRE Q4 2025 Earnings — Fortrea Holdings Inc. Revenue & Financial Results | Market Cap Arena

FTREFortrea Holdings Inc.

$851M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$661M-5.2% YoY

Gross Profit

$112M16.9% margin

Operating Income

$9M1.3% margin

Net Income

-$33M-4.9% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

-5.8%

Cash Flow

Operating Cash Flow

$129M

Free Cash Flow

$122M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$2.7B

Total Liabilities

$2.2B

Stockholders' Equity

$564M

Cash & Equivalents

$175M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$661M	$697M	-5.2%
Gross Profit	$112M	$141M	-20.7%
Operating Income	$9M	-$56M	+115.8%
Net Income	-$33M	-$61M	+46.9%

Revenue Segments

Clinical Services Segment

$661M100%

Geographic Segments

North America

$303M46%

Europe

$220M33%

Other Geographical Areas

$138M21%